Analysts have clear opinions on RH.

There are 5 analysts on the Wall offering 12 month price targets for Pfizer in the last 3 months. The average price target is $41.26 with a high forecast of $46.00 and a low forecast of $37.00. The average price target represents a 2.28% increase from the last price of $40.34.
RH (RH) is followed by 5 analysts on the street.

Randall Stanicky from RBC Capital rates it a Buy with a target of $46.00.

Similarly, Last month David Risinger of Morgan Stanley Reiterated a Hold with a target of $43.00.

The consensus on the street is Hold.

What does RH(RH) do ?
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

RH (RH) Insider Trades

Multiple company employees have indulged in significant insider trading. RH disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

Dir, Gottlieb Scott : P – Purchase(+$104,160) of RH in the trading session of 2019-08-23.

EVP Damelio Frank A : S – Sale(-$6,753,385) of RH in the trading session of 2019-07-02.

EVP Mackenzie Alexander R : S – Sale(-$1,320,000) of RH in the trading session of 2019-06-20.

Looking for stocks just like RH?

Based on Wall Street analyst research, several stocks are similar to RH
They are:
– LLY [Info can be found here: ]
– MRK [Info can be found here: ]
– NVS [Info can be found here: ]